Machine Learning and BMI Improve the Prognostic Value of GAP Index in Treated IPF Patients
Patients affected by idiopathic pulmonary fibrosis (IPF) have a high mortality rate in the first 2–5 years from diagnosis. It is therefore necessary to identify a prognostic indicator that can guide the care process. The Gender-Age-Physiology (GAP) index and staging system is an easy-to-calculate pr...
Main Authors: | Donato Lacedonia, Cosimo Carlo De Pace, Gaetano Rea, Ludovica Capitelli, Crescenzio Gallo, Giulia Scioscia, Pasquale Tondo, Marialuisa Bocchino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/10/2/251 |
Similar Items
-
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis
by: James Patrick Finnerty, et al.
Published: (2021-12-01) -
Long-Term Safety of Antifibrotic Drugs in IPF: A Real-World Experience
by: Stefano Levra, et al.
Published: (2022-12-01) -
Historical eye on IPF: a cohort study redefining the mortality scenario
by: Sara Tomassetti, et al.
Published: (2023-06-01) -
The role of nintedanib and pirfenidone in the treatment of idiopathic pulmonary fibrosis and review of recent clinical trials of IPF therapy
by: Michał Żuber, et al.
Published: (2024-06-01) -
Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study
by: V. Poletti, et al.
Published: (2021-02-01)